Skip to main content

Advertisement

Table 1 Summary of reviewed articles

From: Quality of life and emotional distress in advanced prostate cancer survivors undergoing chemotherapy

Authors Chemotherapeutic agent QOL measure Direction of effect
Tannock et al. (1996) Mitoxantrone EORTC QLQ-30; Pain rating Improved pain, mood & physical activity
Beer et al., (2001) Docetaxel Present Pain Intensity scale Improved pain
Sinibaldi et al. (1999) Docetaxel Brief Pain Inventory Improved pain
Copur et al. (2001) Docetaxel Numeric rating scale Improved pain
Gravis et al. (2003) Docetaxel EORTC QLQ-30; Pain VAS Improved role, social functioning, overall QOL, pain, fatigue, constipation
Small et al. (2000) Suramin Brief Pain Inventory Improved pain
Fuse et al. (1996) Cisplatin/carboplatin Rating scale Improved pain
Kreis et al. (1999). Docetaxel Physician-graded events Presence of fatigue dose-limiting factor
Hamilton et al. (2003) Vinblastine Physician-graded events Presence of fatigue dose-limiting factor
van Andel et al. (2003) Epirubicin QLQ-30 Reduced fatigue, transient improvement in emotional, social and cognitive functioning
Kornblith et al. (2001) Docetaxel FACT-P, Mental Health Inventory-17 Transient improvements in emotional well-being, improved overall QOL